Mass layoffs in Australia

Quote

anonymous

Guest
We have been waiting for a restructure for over 6 months and it finally arrived last Wednesday. Reduction in sales force of just under 50% across the Diabetes and Resp sales force including some first line sales managers and the Respiratory Business Unit Head. Moving to a portfolio sell of Breztri, Forxiga and Symbicort.

We knew this was coming when just over a year ago senior management went on a national roadshow promoting a new digital platform ‘Accelearte/Omnichannel’. Touting it as ‘giving the customers what they want’ (more spam they wont open). Lacklustre Breztri launch meant that mostly Resp reps got canned.

Wandering if Omnichannel has been launched in other markets or whether Australia is the test market before a global launch?



0
 




Omnichannel is all the rage in the USA. Thanks for the heads up on what we can expect. I have learned to never trust anyone in authority at AZ. Most would sell their sister into sex slavery if it made them look good for the next promotion. But, lets all lie on the PULSE survey coming right around the corner.
 




Owning Agility and Onnichannel is all the rage currently. I anticipate layoffs across all divisions within the US given the tough market and struggles with Breztri, Farxiga & even CV. This is not the same AZ.
 








Home office is seriously considering drastic measures on our company vehicles/ fuel because of the explosion in gas costs caused by terrible decisions at the top of IS government
 




anonymous said:
Owning Agility and Onnichannel is all the rage currently. I anticipate layoffs across all divisions within the US given the tough market and struggles with Breztri, Farxiga & even CV. This is not the same AZ.
Click to expand...
Layoffs in CV are coming. Recently I was in HQ and could see the tension. SFO and ZS are active again!!! This'll be the 3rd year in a row layoffs..........
 




Agree. Brilinta is the money maker but post COVID, numbers aren't the same. Farxiga is a battle we are losing, every single day, Hq likes to remind us. Kim G is in a panic and all CBDs are too.
 




anonymous said:
Agree. Brilinta is the money maker but post COVID, numbers aren't the same. Farxiga is a battle we are losing, every single day, Hq likes to remind us. Kim G is in a panic and all CBDs are too.
Click to expand...

You have brand teams with rotating carousels of people looking for the next "check the box" position. Most have been in actual pharma sales for a red hot minute if they have at all. Strategies and ideas very often are rehashed ideas from a couple of years earlier but packaged like they are the euphonies of euphonies.

CBD's tout how awesome these ideas and strategies are and DSM's and PSS's smile and applaud on the surface. Then roll their eyes and continue to do what they know works. It's a game every TA plays.
 












anonymous said:
Agree. Brilinta is the money maker but post COVID, numbers aren't the same. Farxiga is a battle we are losing, every single day, Hq likes to remind us. Kim G is in a panic and all CBDs are too.
Click to expand...
so sorry to hear this. Kim G is the deal. She is an excellent leader and someone will profit if she is lost to AZ. AZ USA
 








anonymous said:
Agree. Brilinta is the money maker but post COVID, numbers aren't the same. Farxiga is a battle we are losing, every single day, Hq likes to remind us. Kim G is in a panic and all CBDs are too.
Click to expand...

Certainly doesn't help when we get crazy Q3 goals with shit resources. Let's begin with INCREASING samples. God, pharma 101.
 




Top Bottom
Back
Quote